73 related articles for article (PubMed ID: 7164018)
1. Decreased levels of histidine-rich glycoprotein (HRG) and increased levels of free plasminogen in women on oral contraceptives low in estrogen.
Jespersen J; Kluft C
Thromb Haemost; 1982 Dec; 48(3):283-5. PubMed ID: 7164018
[TBL] [Abstract][Full Text] [Related]
2. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Jespersen J; Kluft C
Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
[TBL] [Abstract][Full Text] [Related]
3. Estrogens reduce plasma histidine-rich glycoprotein (HRG) levels in a dose-dependent way.
Hennis BC; Boomsma DI; Fijnvandraat K; Gevers Leuven JA; Peters M; Kluft C
Thromb Haemost; 1995 Mar; 73(3):484-7. PubMed ID: 7667832
[TBL] [Abstract][Full Text] [Related]
4. Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis.
Leebeek FW; Kluft C; Knot EA; De Maat MP
J Lab Clin Med; 1989 Apr; 113(4):493-7. PubMed ID: 2703760
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle.
Jespersen J; Kluft C
Thromb Haemost; 1986 Jun; 55(3):388-9. PubMed ID: 3092396
[TBL] [Abstract][Full Text] [Related]
6. Congenital histidine-rich glycoprotein deficiency.
Shigekiyo T; Ohshima T; Oka H; Tomonari A; Azuma H; Saito S
Thromb Haemost; 1993 Aug; 70(2):263-5. PubMed ID: 8236132
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
8. Serum histidine-rich glycoprotein during pregnancy and hormone treatment.
Haukkamaa M; Morgan WT; Koskelo P
Scand J Clin Lab Invest; 1983 Nov; 43(7):591-5. PubMed ID: 6658374
[TBL] [Abstract][Full Text] [Related]
9. Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen.
Kluft C; Los P
Thromb Haemost; 1988 Dec; 60(3):411-4. PubMed ID: 2467400
[TBL] [Abstract][Full Text] [Related]
10. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
Norris LA; Bonnar J
Thromb Haemost; 1994 Dec; 72(6):926-30. PubMed ID: 7740465
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
12. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
13. Individual levels of plasma alpha 2-antiplasmin and alpha 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
Jespersen J; Sidelmann J
Thromb Haemost; 1983 Aug; 50(2):581-5. PubMed ID: 6195752
[TBL] [Abstract][Full Text] [Related]
14. Hereditary increase of plasma histidine-rich glycoprotein associated with abnormal heparin binding (HRG Eindhoven).
Hoffmann JJ; Hennis BC; Kluft C; Vijgen M
Thromb Haemost; 1993 Dec; 70(6):894-9. PubMed ID: 8165607
[TBL] [Abstract][Full Text] [Related]
15. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
Poon IK; Olsson AK; Hulett MD; Parish CR
Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Coenen CM; Thomas CM; Borm GF; Rolland R
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
[TBL] [Abstract][Full Text] [Related]
17. A sequential study of plasma histidine-rich glycoprotein and plasminogen in patients with acute myocardial infarction and deep vein thrombosis.
Jespersen J; Gram J; Bach E
Thromb Haemost; 1984 Feb; 51(1):99-102. PubMed ID: 6719393
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
19. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
20. Rationale for new oral contraceptive dosing.
Williams JK
Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
